Fractalkine Antibodies

Santa Cruz Biotechnology delivers a wide array of Fractalkine monoclonal antibodies for various research applications. Fractalkine monoclonal antibodies are recommended for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fractalkine, also known as CX3CL1, plays a crucial role in the immune response by mediating the adhesion and migration of immune cells to sites of inflammation. The unique structure of Fractalkine enables it to function both as a chemoattractant and an adhesion molecule, making it distinct from other chemokines. Fractalkine is involved in various physiological processes, including neuroinflammation and cardiovascular health, making it a significant target for research in these areas. Understanding the function of Fractalkine is essential for developing therapeutic strategies for diseases characterized by chronic inflammation. Researchers studying inflammatory conditions can utilize Fractalkine monoclonal antibodies to explore cellular signaling pathways and molecular mechanisms. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise investigation of Fractalkine's role in health and disease states.